Effect of renin inhibition on an experimental glomerulonephritis - a preliminary report |
Kang, Ju-Hyung
(Department of Pediatrics, College of Medicine, Eulji University)
Heo, Jae-Kyung (Department of Pediatrics, College of Medicine, Eulji University) Lee, Young-Sook (Department of Internal Medicine, College of Medicine, Eulji University) Han, Ji-Young (Clinical Research Institute, Seoul National University Hospital) Ha, Il-Soo (Department of Pediatrics, College of Medicine, Seoul National University) |
1 | Rongen GA, Lenders JW, Smits P, Thien T. Clinical pharmacokinetics and efficacy of renin inhibitors. Clin Pharmacokinet 1995;29:6-14 DOI ScienceOn |
2 | Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM et al. Acute angiotensin converting enzyme inhibition increases the plasma level of the natural stem-cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline. J Clin Invest 1996;97:839-44 DOI |
3 | Yayama K, Matsui T, Takano M, Hayashi K, Nagamatsu T, Suzuki Y, et al. Activation of the renin-angiotensin system in anti-glomerular basement membrane antibody-induced glomerulonephritis. Biol Pharm Bull 1995;18:411-5 DOI PUBMED ScienceOn |
4 | Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation 2005;111:1012-8 DOI ScienceOn |
5 | Karlberg BE. Cough and inhibition of the renin-angiotensin system. J Hypertens 1993;11:S49-S52 DOI |
6 | Hong L, Rateri DL, Feldman DL, Charnigo RJ, Fukamizu A, Ishida J, et al. Renin inhibition reduces hypercholesterolemia- induced atherosclerosis in mice. J clin Invest 2008;118:984-93 ScienceOn |
7 | Todd PA, Heel RC. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 1986;31: 198-248 DOI ScienceOn |
8 | Stanton A. Potential of renin inhibition in cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2003;4:6-10 DOI ScienceOn |
9 | Carey RM, Siragy HM. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003;24:261-71 DOI ScienceOn |
10 | Rahuel J, Rasetti V, Maibaum J, Rueger H, Goschke R, Cohen NC, et al. Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin. Chem Biol 2000;7:493-504 DOI ScienceOn |
11 | Kagami S, Border WA, Ruoslahti E, Noble NA. Coordinated expression of beta 1 integrins and transforming growth factor-β induced matrix proteins in glomerulonephritis. Lab Invest 1993;69:68-76 ScienceOn |
12 | Yoo TH, Ryu DR, Lee JJ, Kim JJ, Jung DS, Kwak SJ, et al. The effect of high glucose on renin-angiotensin system (RAS) in podocytes. Korean J Nephrol 2006;25:903-12 |
13 | Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, et al. Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kid Int 2006;69:105-13 DOI ScienceOn |
14 | Salant DJ, Cybulsky AV: Experimental glomerulonephritis. Method Enzymol 1988;162:421-61 |
15 | Zhao Y, Biermann T, Luther C, Unger T, Culman J, Gohlke P. Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells. J Neurochem 2003;85:759-67 DOI PUBMED ScienceOn |
16 | Hernandez R, Sosa-Canache B, Velasco M, Armas-Hernandez MJ. Armas-Padilla MC, Cammarata R. Angiotensin II receptor antagonists role in arterial hypertension. J Hum Hypertens 2002;16(Suppl 1):S93-9 ScienceOn |
17 | Nguyen G, Burckle C, Sraer JD. The renin receptor: the facts, the promise and the hope. Curr Opin Nephrol Hypertens 2003;12:51-5 DOI ScienceOn |
18 | Fisher ND, Hollenberg N. Renal vascular responses to renin inhibition with zankiren in men. Clin Pharmacol Ther 1995; 57:342-8 DOI ScienceOn |
19 | Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin (1-7): an evolving story in cardiovascular regulation. Hypertension 2006;47:515-21 DOI PUBMED ScienceOn |
20 | Mezzano SA. Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension 2001;38:635-8 DOI ScienceOn |
21 | Michel A. Direct renin inhibition:clinical pharmacology. J Mol Med 2008;86:647-54 DOI ScienceOn |
22 | Dzau VJ. Theodore Cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001;37:1047-52 PUBMED ScienceOn |
23 | Azizi M, Menard J. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation 2004;109:2492-9 DOI ScienceOn |
24 | Kunz R, Friedrich C, Wolbers M, Mann JF. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med 2008;148:30-48 DOI PUBMED |
25 | Kim JH, Ha IS, Hwang CI, Lee YJ, Kim JH, Yang SH, et al. Gene expression profiling of anti-GBM glomerulonephritis model: The role of NF-κB in immune complex kidney disease. Kid Int 2004;66:1826-37 DOI ScienceOn |
26 | Ibrahim MM. RAS inhibition in hypertension. J Hum Hypertens 2006;20:101-8 DOI PUBMED ScienceOn |